<DOC>
	<DOCNO>NCT00047788</DOCNO>
	<brief_summary>The primary objective ass efficacy ZD6474 give orally patient relapse multiple myeloma . A minimum 15 maximum 30 evaluable patient enter study</brief_summary>
	<brief_title>Efficacy Study ZD6474 Treat Multiple Myeloma Cancer</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Confirmed diagnosis multiple myeloma . Patients must minimum serum Mprotein level &gt; =10g/L serum protein electrophoresis patient light chain disease , minimum BenceJones protein 1g/24 hr . Patients must receive prior treatment multiple myeloma : patient may receive 1 2 prior regimen oral alkylating base chemotherapy must relapse follow treatment ( &gt; = 3 month ) OR patient may relapse follow high dose chemotherapy SCT first line treatment provide treatment . Lab inclusion AGC &gt; = 1.0 x10_9/L platelet &gt; = 50 x10_9/L Bilirubin , AST and/or ALT &lt; = 1.5 x UNL ; creatinine &lt; 2 x UNL , Potassium &gt; = 4.0 mmol/L ; calcium magnesium within normal limitsÂ· Patients may &gt; 2 prior regimen chemotherapy and/or prior thalidomide treatment . Patients may nonalkylating base chemotherapy . Patients history malignancy , except : adequately treat nonmelanoma skin cancer , curatively treated insitu cancer cervix , solid tumour curatively treat evidence disease &gt; = 5 year . Pregnant lactating woman . Women childbearing potential must negative pregnancy test within 7 day prior registration must use effective contraception throughout study . Patients relapse treatment oral alkylating chemotherapy . Patients receive 2 prior regimen chemotherapy . Patients receive excluded medication exclude medical condition . Patients receive nonalkylating base chemotherapy regimens initial therapy , therapy recurrent disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Relapsed Multiple Myeloma</keyword>
</DOC>